ABVC
Price
$3.01
Change
-$0.24 (-7.38%)
Updated
Jul 25 closing price
Capitalization
51.11M
MLEC
Price
$3.15
Change
-$0.15 (-4.55%)
Updated
Jul 25 closing price
Capitalization
12.6M
93 days until earnings call
Interact to see
Advertisement

ABVC vs MLEC

Header iconABVC vs MLEC Comparison
Open Charts ABVC vs MLECBanner chart's image
ABVC BioPharma
Price$3.01
Change-$0.24 (-7.38%)
Volume$218K
Capitalization51.11M
Moolec Science SA
Price$3.15
Change-$0.15 (-4.55%)
Volume$106.49K
Capitalization12.6M
ABVC vs MLEC Comparison Chart in %
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVC vs. MLEC commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Hold and MLEC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ABVC: $3.01 vs. MLEC: $3.15)
Brand notoriety: ABVC and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 44% vs. MLEC: 150%
Market capitalization -- ABVC: $51.11M vs. MLEC: $12.6M
ABVC [@Biotechnology] is valued at $51.11M. MLEC’s [@Biotechnology] market capitalization is $12.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 0 FA rating(s) are green whileMLEC’s FA Score has 0 green FA rating(s).

  • ABVC’s FA Score: 0 green, 5 red.
  • MLEC’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVC is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 3 TA indicator(s) are bullish while MLEC’s TA Score has 4 bullish TA indicator(s).

  • ABVC’s TA Score: 3 bullish, 5 bearish.
  • MLEC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MLEC is a better buy in the short-term than ABVC.

Price Growth

ABVC (@Biotechnology) experienced а -10.15% price change this week, while MLEC (@Biotechnology) price change was -18.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ABVC is expected to report earnings on Apr 15, 2025.

MLEC is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVC($51.1M) has a higher market cap than MLEC($12.6M). ABVC YTD gains are higher at: 410.170 vs. MLEC (-60.625). ABVC has higher annual earnings (EBITDA): -2.31M vs. MLEC (-5.24M). MLEC has more cash in the bank: 926K vs. ABVC (217K). ABVC has less debt than MLEC: ABVC (2.17M) vs MLEC (22.1M). MLEC has higher revenues than ABVC: MLEC (7.83M) vs ABVC (508K).
ABVCMLECABVC / MLEC
Capitalization51.1M12.6M406%
EBITDA-2.31M-5.24M44%
Gain YTD410.170-60.625-677%
P/E RatioN/AN/A-
Revenue508K7.83M6%
Total Cash217K926K23%
Total Debt2.17M22.1M10%
FUNDAMENTALS RATINGS
ABVC: Fundamental Ratings
ABVC
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVCMLEC
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
53%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
58%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 20 days ago
59%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SST7.510.42
+5.92%
System1
TSHA2.650.06
+2.32%
Taysha Gene Therapies
AX84.720.19
+0.22%
Axos Financial
IHT2.24N/A
N/A
InnSuites Hospitality Trust
PPL36.57-0.01
-0.03%
PPL Corp

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
-7.38%
KNSA - ABVC
40%
Loosely correlated
-2.12%
MRSN - ABVC
33%
Loosely correlated
-4.38%
MLEC - ABVC
31%
Poorly correlated
-4.45%
FULC - ABVC
27%
Poorly correlated
-0.13%
MDXXF - ABVC
25%
Poorly correlated
+0.28%
More

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with WINT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
-4.45%
WINT - MLEC
49%
Loosely correlated
-3.92%
CTMX - MLEC
42%
Loosely correlated
+0.42%
AAVXF - MLEC
38%
Loosely correlated
+2.17%
ABEO - MLEC
36%
Loosely correlated
-1.80%
ABVC - MLEC
31%
Poorly correlated
-7.38%
More